Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Novartis bought 52% stake from Nestlé for $28.1 Billion. This deal brought the total ownership of Alcon by Novartis to 77%. Beginning January 2010 Novartis formally announced it will be completing the exercise options for finishing purchasing the rest of Alcon and then promptly continue to exercise merger and takeover of Alcon. [12] [13]

  3. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  4. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis AG. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

  5. List of Nestlé brands - Wikipedia

    en.wikipedia.org/wiki/List_of_Nestlé_brands

    Nestlé owned 100% of Alcon in 1978. In 2002 Nestlé sold 23.2% of its Alcon shares on the New York Stock Exchange. In 2008 Nestlé sold 24.8% of existing Alcon shares to the Swiss pharmaceutical giant Novartis. In 2010 Nestlé sold the remaining 52% of its Alcon shares to Novartis. Novartis paid a total of 39.1 bn USD.

  6. Novartis Aims to Beat $1.9B in Cost Savings By Year's End - AOL

    www.aol.com/2011/09/13/novartis-aims-to-beat-19b...

    Novartis (NYS: NVS) has two things to say. It now expects more bang for its buck from Alcon. The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double ...

  7. Novartis in advanced talks to buy Cytokinetics- source - AOL

    www.aol.com/news/novartis-advanced-talks-buy...

    (Reuters) -Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

  8. AOL Mail is free and helps keep you safe.

    mail.aol.com/?rp=webmail-std/en-us/basic

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  9. Alcon Entertainment - Wikipedia

    en.wikipedia.org/wiki/Alcon_Entertainment

    Alcon Entertainment, LLC is an American independent film and television production company, founded in 1997 by film producers Broderick Johnson and Andrew Kosove.Since its establishment, Alcon Entertainment has developed and financed films that are ultimately distributed – in the United States mostly, and internationally on occasion – by Warner Bros. Pictures, following a ten-year motion ...